Therapeutic Potential of Targeting SK1 in Human Cancers
Heba Alshaker(University of East Anglia), Dmitri Pchejetski(University of East Anglia), Danielle Monteil(Naval Medical Center Portsmouth), Torsten Böhler(Charité - Universitätsmedizin Berlin), Lysann Sauer(Centre National de la Recherche Scientifique), Silvia Ottaviani(University of Nottingham), Shyam Srivats
Cited by 56
Related Papers
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|Cancer Cell|2022|403
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174